Can-Fite BioPharma (NYSE:CANF – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at D. Boral Capital in a research report issued on Tuesday,Benzinga reports.

StockNews.com started coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a research report sent to investors on Wednesday. The firm issued a sell rating on the stock.

New Delhi: Mauritius Prime Minister Navin Ramgoolam announced in the National Assembly that Prime Minister Narendra Modi will serve as the Guest of Honour at the country's National Day celebrations.

Can-Fite BioPharma (CANF) announced a significant clinical development: the disappearance of episodes of decompensated liver cirrhosis following treatment with Namodenoson under a compassionate ...

Negotiations on returning the Chagos Islands to Mauritius follow a long-running legal battle by the archipelago’s former residents (Fiona Hanson/PA) Sir Keir Starmer remains “confident” that ...

(RTTNews) - Can-Fite BioPharma Ltd. (CANF), announced on Tuesday that a patient experienced the disappearance of episodes of decompensated liver cirrhosis following treatment with Namodenoson ...

Sir Keir Starmer remains “confident” that a deal can be reached on the Chagos Islands “in the coming weeks”, the prime minister of Mauritius has told his parliament. Answering questions in ...

The UK has denied claims from the prime minister of Mauritius that it could end up paying double under a new Chagos Islands deal. The Foreign Office has said the figures being quoted are "entirely ...